Perennial Investment Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Perennial Investment Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,395	Closed	-$215K	–	226
2022 Q1	$215K	Sell	2,395 -258	-10%	-$23.8K	0.07%	196
2021 Q4	$296K	Sell	2,653 -228	-8%	-$27.5K	0.09%	175
2021 Q3	$364K	Sell	2,881 -24	-0.8%	-$3.09K	0.13%	143
2021 Q2	$393K	Sell	2,905 -4,571	-61%	-$601K	0.14%	125
2021 Q1	$1.01M	Buy	7,476 +427	+6%	+$63.9K	0.4%	55
2020 Q4	$992K	Buy	7,049 +1,075	+18%	+$138K	0.42%	52
2020 Q3	$665K	Buy	5,974 +1,885	+46%	+$211K	0.33%	63
2020 Q2	$458K	Buy	+4,089	New	+$403K	0.31%	65

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Perennial Investment Advisors's XBI Position: Q2 2022 in Review

Perennial Investment Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2022, closing a stake of 2,395 shares — an estimated $215K sold.

Perennial Investment Advisors first reported a position in XBI in Q2 2020 and held it in 8 quarters. The position peaked at $1.01M in Q1 2021. 706 funds tracked by Wall St. Rank hold XBI as of Q2 2022.

Perennial Investment Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2022 after selling out during the quarter.
Perennial Investment Advisors sold 2,395 State Street SPDR S&P Biotech ETF shares in Q2 2022, an estimated $215K.
Perennial Investment Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 8 quarters.
Perennial Investment Advisors's State Street SPDR S&P Biotech ETF position peaked at $1.01M in Q1 2021.
706 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2022.

Based on Perennial Investment Advisors's 13F filing for Q2 2022, filed 10 Aug 2022.